Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Arthritis Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Arthritis Other
    Diclofenac Epolamine Topical Patch Efficacious and Safe in Elderly Patients With Acute Periarthritis: Presented at AGS - (DGDispatch)
    Novel Urate-Lowering Agent, Febuxostat, Shows Better Results in Older Adults With Gout Compared With Allopurinol: Presented at AGS - (DGDispatch)
    Febuxostat Approved in Europe for the Treatment of Chronic Hyperuricaemia in Patients With Gout - (DGNews)
    Tocilizumab Approved in Japan for the Treatment of Rheumatoid Arthritis - (DGNews)
    FDA Approves Abatacept for the Treatment of Polyarticular Juvenile Idiopathic Arthritis - (DGNews)

    News archive

     Recent webcasts/CME - Arthritis Other
    • Beyond Efficacy and Safety in Rheumatoid Arthritis Treatment: Quality-of-Life Outcomes With Newer Biologics in RA
    • Beyond Efficacy and Safety in Rheumatoid Arthritis Treatment: Quality-of-Life Outcomes With Newer Biologics in RA
    • Long-Term Data on Abatacept and Rituximab Show Continued Efficacy in Rheumatoid Arthritis
    • Inflammatory Arthritis -The Antisynthetase Syndrome
      Inflammatory Arthritis - Gout

      Webcasts/CME archive

       Recent cases - Arthritis Other
        Bilateral Sternoclavicular Joint Septic Arthritis Secondary to Indwelling Central Venous Catheter: A Case Report
        Bowel Associated Dermatosis - Arthritis Syndrome: A Case Report
        Streptobacillus Moniliformis Septic Arthritis: A Clinical Entity Distinct from Rat-Bite Fever?
        Reactive Arthritis of the Temporomandibular Joints and Cervical Spine in a Child
        Reactive Arthritis Developing after Pneumococcal Conjunctivitis: A Case Report

        Cases archive
          




        my personal edition > arthritis other > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Gene May Link Inflammatory Disease Of Spine/Joints, Skin, Eye And Bowel

        A DGReview of :"Inflammatory Eye, Skin, and Bowel Disease in Spondyloarthritis: Genetic, Phenotypic, and Environmental Factors"
        Journal of Rheumatology

        12/14/2001
        By Anne MacLennan


        A shared gene may account for a striking overlap of rheumatological, dermatological, and gastroenterological diseases within patients and family members.

        This is the suggestion of a study of genetic, phenotypic and environmental factors in inflammatory eye, skin and bowel disease in spondyloarthritis.

        Study objective was to explore the nature of the interrelationship between inflammatory disease of the spine/joints, skin, eye, and bowel (ie, ankylosing spondylitis [AS], psoriasis, iritis, inflammatory bowel disease [IBD]).

        The researchers used four different approaches: 1) analysis of the prevalence of secondary disorders within the AS individual (chi-square and matched pair analysis); 2) study of the temporal relationship between the onset of the different conditions; 3) evaluation of the prevalence of disease among first-degree relatives; and 4) influence of secondary disorders on outcome of AS.

        Study participants were 3,287 patients with AS. Among these patients, more than expected had either spondylitis linked with multiple co-disorders or pure AS (with no co-diseases); fewer than expected had AS plus a single co-disease.

        In a matched pair analysis, patients with AS and a secondary disorder were more likely to have an additional concomitant disease.

        For example, compared with controls, the 335 patients with IBD-AS had a higher prevalence of iritis (45.4 percent versus 36.7 percent) or psoriasis (23.9 percent vs. 14.3 percent).

        Among subjects in the study database, the symptomatic onset of the spinal disease precedes or is contemporaneous with gut, skin, and eye involvement.

        Patients with multiple disorders predict the highest prevalence of co-diseases (ie, psoriasis, IBD, iritis, or AS) within family members, followed by those AS patients with only IBD, psoriasis, or iritis in descending order.

        Both psoriasis and IBD increase severity in terms of function and disease activity of AS in the patient. Radiological change is greatest for those AS subjects with iritis.

        Thus, in summary, these authors note the susceptibility genes of inflammatory disease of the spine/joints, skin, eye, and bowel appear to overlap with each over and AS.

        A patient with two inflammatory conditions is at an increased risk of developing an additional related inflammatory disorder.

        People with enteropathic spondylarthritis would appear to carry the greatest genetic load in terms of first-degree relatives developing inflammatory conditions (including psoriasis and iritis that are not seen in the index IBD-AS patient).

        The secondary disorders do not precede AS, which argues against psoriasis and IBD allowing for an environmental conduit to pathogenic triggers in AS.

        Thus, the susceptibility factors for these inflammatory conditions may be additive or have a synergistic effect on each other, and there is evidence for a shared gene hypothesis, study authors conclude.
        J Rheumatol 2001;28:2667-73. "Inflammatory Eye, Skin, and Bowel Disease in Spondyloarthritis: Genetic, Phenotypic, and Environmental Factors"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send